| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
| PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |
| HLA-DQA2 |
P01906
|
major histocompatibility complex, class II, DQ alpha 2
|
Immune response
|
1.0E-05 |
0.617 |
0.769 |
| TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
| EHMT2 |
Q96KQ7
|
euchromatic histone lysine methyltransferase 2
|
Epigenetic regulator
|
1.0E-04 |
0.590 |
0.808 |
| BTNL2 |
Q9UIR0
|
butyrophilin like 2
|
Enzyme modulator
|
8.6E-11 |
0.546 |
0.808 |
| POU5F1 |
Q01860
|
POU class 5 homeobox 1
|
|
0.95 |
0.441 |
0.846 |
| STK19 |
P49842
|
serine/threonine kinase 19
|
|
6.7E-09 |
0.691 |
0.500 |
| PRRC2A |
P48634
|
proline rich coiled-coil 2A
|
Enzyme
|
1.00 |
0.656 |
0.654 |
| EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
| HLA-DMB |
P28068
|
major histocompatibility complex, class II, DM beta
|
Immune response
|
2.5E-03 |
0.638 |
0.615 |
| SFTA2 |
Q6UW10
|
surfactant associated 2
|
|
3.6E-02 |
0.695 |
0.577 |
| MUCL3 |
Q3MIW9
|
mucin like 3
|
|
1.2E-05 |
0.691 |
0.731 |
| TCF19 |
Q9Y242
|
transcription factor 19
|
|
9.4E-04 |
0.674 |
0.692 |
| PPT2-EGFL8 |
|
PPT2-EGFL8 readthrough (NMD candidate)
|
|
|
0.792 |
0.462 |
| PPT2 |
Q9UMR5
|
palmitoyl-protein thioesterase 2
|
Enzyme
|
4.5E-03 |
0.751 |
0.500 |
| RNF5 |
Q99942
|
ring finger protein 5
|
Enzyme
|
3.7E-05 |
0.716 |
0.538 |
| EGFL8 |
Q99944
|
EGF like domain multiple 8
|
Calcium-binding protein
|
1.1E-07 |
0.792 |
0.269 |
| GPANK1 |
O95872
|
G-patch domain and ankyrin repeats 1
|
|
3.2E-07 |
0.769 |
0.385 |